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The expression signature of in vitro senescence and aging. <p>A comparison of several microarray datasets from aging human, mouse and rat and datasets from senescent cells from human and  mouse shows a similarity between the expression signatures of cellular senescence and aging in mouse but not in humans.</p>
Abstract
Background: The biological mechanisms that underlie aging have not yet been fully identified.
Senescence, a phenomenon occurring in vitro, limits the number of cell divisions in mammalian cell
cultures and has been suggested to contribute to aging.
Results: We investigated whether the changes in gene expression that occur during mammalian
aging and induction of cellular senescence are similar. We compared changes of gene expression in
seven microarray datasets from aging human, mouse and rat, as well as four microarray datasets
from senescent cells of man and mouse. The datasets were publicly available or obtained from
other laboratories. Correlation measures were used to establish similarities of the expression
profiles and gene ontology analyses to identify functional groups of genes that are co-regulated.
Robust similarities were established between aging in different species and tissues, indicating that
there is an aging transcriptome. Although some cross-species comparisons displayed high
correlation, intra-species similarities were more reliable. Similarly, a senescence transcriptome was
demonstrated that is conserved across cell types. A similarity between the expression signatures
of cellular senescence and aging could be established in mouse, but not in human.
Conclusion: Our study is the first to use microarray data from several studies and laboratories
for dissection of a complex biological phenotype. We demonstrate the presence of a mammalian
aging transcriptome, and discuss why similarity between cellular senescence and aging is apparent
in aging mice only.
Background
In vitro senescence was discovered as a phenomenon that
limits the replicative lifespan of cells grown in culture, and
was immediately hypothesised to be a possible cause of
human aging [1,2]. During several decades, attempts have
been made to establish a link between the age and the replica-
tive potential of cells derived from humans [3]. Although sev-
eral studies have shown a correlation between in vivo and in
vitro life span, these results have been questioned and re-
evaluated [4]. A more convincing approach to establish a link
between cellular senescence and aging would be to detect
senescent cells in vivo. Unfortunately, no good senescence
marker exists, except for senescence-associated β -galactosi-
dase (SAβ -gal) staining [5]. This technique has been used
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extensively but its specificity has been questioned [6]. A cor-
relation between human age and an accumulation of SA-β
GAL staining cells has been reported [5] but, for unknown
reasons, could not be repeated [4]. In mice, increased SAβ -
GAL staining has been reported in animals harbouring the
Werner mutation and short telomeres, which gives rise to an
aging phenotype [7], following chemotherapeutic treatment
[8], in liver regeneration after partial hepatectomy in animals
with short telomeres [9] and upon aging [10]. These studies
indicate that senescent cells could exist in vivo but do not pro-
vide any measure of their relative contribution to the aging
process.
In the current study, publicly available microarray data
describing both aging and in vitro senescence were used. By
comparing the expression changes that occur during aging in
human, mouse and rat across several tissues, we conclude
that there is a mammalian aging expression signature. This
expression signature is mainly conserved within species,
independent of organ, but also highly conserved between
some organs between species. Using a similar approach, we
also establish that the expression signature of in vitro senes-
cence has similarity to that of in vivo aging in mouse but not
human. This indicates differences between human and
mouse aging and suggests that senescence might contribute
to aging in mice but not humans.
Results
A shared expression profile of aging in mammals
Previous studies have indicated that there is a conserved
genetic program for aging across species of low complexity
[11]. To date, however, no comprehensive data have indicated
that aging in mammals is conserved across species. If a
genetic program for aging exists in mammals, it could be con-
served across species independent of tissue type, or it could
be organ specific. Given the expansion of the microarray field
during the past years, resulting in an accumulation of expres-
sion datasets in the literature and public databases, we
thought that sufficient data were present to enable a study of
gene expression signatures during mammalian aging. The
multitude of different platforms used to study global expres-
sion changes makes such an approach challenging from a
data analysis perspective. To make our study possible, we had
to control for a possible bias across platforms and species. To
achieve this, we calculated a log-transformed ratio of change
Table 1
Included aging studies
Study Chip type Species Tissue Age
Welle et al. [26] HG U133 A+B Human Skeletal muscle Old (n = 16) 66-77 years
Young (n = 15) 21-24 years
Lu et al. [27] HG U95 Av2 Human Frontal cortex of brain Old (n = 11) 73-106 years
Young (n = 10) 26-42 years
Rodwell et al. [28] HG U133 A+B Human Kidney cortex and medulla Old (n = 28) 72-92 years
Young (n = 11) 27-45 years
Lee et al. [25] MU 6500 Mouse Cerebellum and neocortex 
of brain
Old (n = 2/3*) 30 months
Young (n = 3) 5 months
Lee et al. [29] MG U74 A Mouse Heart Old (n = 5) 30 months
Young (n = 5) 5 months
Blalock et al. [30] RG U34 A Rat Hippocampus, brain Old (n = 10) 24 months
Young (n = 9) 4 months
All studies of aging that were used in the aging to aging, and the aging to senescence comparisons are listed. Platform, species, tissues and grouping 
details for each study are shown. The Lee et al. [25] data was analyzed as two separate datasets, as it contained data from two different tissues - 
cerebellum and neocortex, and data on the aging CNS of other species was available for comparison.
Method for quantifying similarity between gene expression profiles and assessing significance Figure 1 (see following page)
Method for quantifying similarity between gene expression profiles and assessing significance. (a) The aging to young ratio of gene expression is calculated 
and log-transformed for all genes or orthologous genes present on both of the compared microarrays. Ortholog pairs need to be identified in cross-
species comparisons. (b) Two example scatter plots for comparisons of change in gene expression with age. The calculated correlations (Pearson; R) are 
displayed to the lower right in the plots. (c-e) A distribution of correlations is produced by randomly pairing the genes present on both microarrays 
10,000 times and calculating the Pearson correlation for each permutation. The distribution of random correlations (Monte Carlo simulation) is displayed 
as a density curve in (e). The actual correlation, indicated by an arrow in (e), can then be compared to the random distribution of correlations.http://genomebiology.com/2005/6/13/R109 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. R109.3
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Figure 1 (see legend on previous page)
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in gene expression between old and young tissues, for each
individual gene in each study. These relative gene expression
measures could then be compared to the measures of the
same gene, or orthologous gene, in other datasets (Figure 1a).
The extent of similarity in a comparison can be visualised
using scatter plots (Figure 1b), and a correlation can be calcu-
lated to quantify the similarity. It is also necessary, however,
to establish what should be considered a significant correla-
tion and what should not. To do this, we used a randomisation
approach (Monte Carlo simulation) described in Figure 1c-d.
The simulation approximates the likelihood of finding corre-
lation in a comparison if there is no underlying similarity, and
can be used to calculate a P value for the observed correlation.
A survey of public databases and PubMed identified seven
datasets of human, mouse and rat aging that passed technical
and quality standards (Materials and methods and Table 1).
To look for an aging signature, we compared all seven aging
datasets with each other. The density curves of the obtained
correlation measures from 10,000 permutations together
with the achieved correlation in that comparison are dis-
played in Figures 2 and 3a (Pearson correlations are dis-
played throughout this report but similar results were
achieved using Spearman and Kendall correlation measures).
Of 21 correlations, 10 seemed highly unlikely to occur by
chance. A t test confirmed that there are shared patterns of
gene regulation with age, with a mean correlation of 0.072 (P
= 0.00039), when the 21 correlations are considered samples
from a hypothetical population of age to age transcriptome
comparisons (Figure 3b). Negligible similarity was obtained
in some comparisons, whereas other comparisons yielded
very high correlations. The maximum correlation was
obtained when comparing mouse neocortex to mouse cere-
bellum (0.28) and could be compared to inter-subject varia-
tion in gene expression following exercise, with correlations
in the same range [12].
3c). The strongest determinant of similarity was species, as
this was the only group demonstrating an average Z-score
that was larger then zero (P = 0.02). Z-scores were preferred
in the comparisons as they contain a significance estimate,
although similar results were obtained when using correla-
tion measures. The results regarding average correlations
within species and tissues indicate a species-specific tran-
scription profile in aging, although some organs show simi-
larities across species (Figure 3c).
We also assessed whether the relationships differed between
species and across tissues. We compared the correlations,
with regard to their displacement (in standard deviations)
from the distribution of simulated correlations, across both
species and tissues (Figure 
Comparing the transcriptomes of in vitro senescence 
and aging
We hypothesised that if senescence is an important mecha-
nism of aging in mammals, then the expression profile of cel-
lular senescence should be detectable in aging tissues. We
used the method described above to assess similarities
between four senescence datasets (Table 2) and aging (Table
1). As shown in Figure 3a (far right), there is a common tran-
scriptional profile of in vitro senescence, as significant simi-
larities were present in five out of six comparisons. The mean
correlation of 0.14 (P = 0.0077 for having a mean equal or
lower than zero) indicates a high degree of similarity across
all senescence datasets (Figure 3b). Averages of intra- and
inter-species correlations were 0.18 and 0.10, respectively,
although it was only possible to compare senescence across
cell types within Homo sapiens. No average similarity was
found in the comparison of in vitro senescence and aging
(Figure 3a, middle section). Of all 55 possible comparisons of
aging and senescence datasets, 19 cases of significant correla-
tion were found, of which 15 were positive and appeared in
the aging-aging and senescence-senescence comparison
groups. Only four, of which one was negative, appeared in the
aging to senescence group, indicating that senescence-like
transcription patterns are not generally present in the exam-
ined aged tissues of man, mouse and rat. The average devia-
tions from the Monte Carlo simulations (Z-score) in the
aging-aging (3.69, p = 0.00091), aging-senescence (0.74, p =
0.12) and senescence-senescence (11.6, p  = 0.032) groups
show that similarity can not be established in the aging-
senescence comparisons (the aging-aging and senescence-
senescence comparisons serve as positive controls).
Although these data would suggest that there are no similari-
ties between senescence and aging, we suspected that this
might reflect the models used in the senescence studies. In
the case of the aging datasets, we compared young and old
tissues, where extensive cell division does not take place. In
the case of the senescence studies, however, the four senes-
cent transcription profiles were generated by comparisons of
logarithmic phase growing cultures to non-growing senescent
cultures. We speculated, therefore, that the difference in
terms of growth-associated transcriptional changes might
obscure the senescence transcriptome signature. To clarify
this we studied Gene Ontology categories and demonstrated
an overrepresentation of categories related to proliferation in
all senescence studies but not in the aging studies (data not
shown). To test the hypothesis that cellular senescence is
indeed similar to aging (if proliferation is not a component of
the comparison), we used two of the datasets where non-
growing quiescent cultures had been used to identify senes-
cence specific - not growth-related - gene expression changes.
The similarities between the senescent datasets that included
a quiescent control were maintained after exchanging the
proliferating control for the quiescent control (the correlation
was 0.22 when compared to proliferating cells and 0.12 when
compared to growth arrested cells).http://genomebiology.com/2005/6/13/R109 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. R109.5
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Interestingly, when we used the two datasets where senescent
cells were compared to quiescent cells and compared these to
the aging profiles, we were able to discover a common expres-
sion profile between mouse aging and senescence but not
human aging and senescence (Figure 4). The average correla-
tion between the senescent datasets and murine aging was
0.094 (P = 0.013). To test whether the similarities were sig-
nificant, we compared the average correlations and Z-scores
Conserved patterns of gene regulation in mammalian aging Figure 2
Conserved patterns of gene regulation in mammalian aging. Twenty-one pair wise comparisons of seven aging datasets, with human, mouse and rat data, 
are displayed. Row and column names indicate the datasets compared. Arrows indicate the Pearson correlation in each comparison. Distributions of 
correlations produced by random pairing of genes are displayed as density curves. P values (calculated using the random correlation distributions as a 
reference) and numbers of gene or ortholog pairs (present in the individual comparison) are displayed in the top right part of each figure.
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Figure 3 (see legend on next page)
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of groups according to Figure 4. These results show that
senescence - or senescence like - patterns of gene expression
share similarity with those of mouse in vivo aging and further
indicate that aging in mouse and human may differ.
To provide additional support for a biological similarity
between senescence and mouse aging, we assessed whether
the genes that gave rise to this correlation corresponded to
biological themes. The contribution of genes associated with
a certain Gene Ontology category to the overall correlation in
a specific comparison can be assessed. For all six comparisons
of senescence and mouse aging, this was done by calculating
the partial summation of the Pearson correlation for all
appearing Gene Ontology categories. We estimated the prob-
ability for chance to produce a correlation between the genes
of each individual Gene Ontology category with Monte Carlo
simulations. All genes or orthologs in the current comparison
were randomly paired and then randomly assigned to Gene
Ontology categories. This was repeated 10,000 times to
produce distributions of correlations, which were used to cal-
culate P values. The results are displayed in Table 3. A con-
spicuous overlap in Gene Ontology categories between the
mouse aging to senescence comparisons was observed. The
finding that Gene Ontology categories in many cases over-
lapped between more than two comparisons indicates that
the similarities between senescence and mouse aging corre-
spond to common biological themes. Several of the significant
Gene Ontology categories related to mitochondria, protein
folding and RNA processing, indicating that these
fundamental cellular processes characterise the similarity
between mouse aging and cellular senescence.
Discussion
This is the first microarray meta-analysis where the compo-
nents of a complex biological phenotype are dissected into its
in vitro parts. An expression signature was identified that is
common to the aging transcriptomes of mouse, man and rat,
and conserved mainly within species, but also within organs
across species. Evidence of a similarity between the gene
expression signatures of aging and cellular senescence was
apparent in mouse but, interestingly, not found in human.
The fundamental tool used in this report was estimates of cor-
relations between gene expression changes in aging and
senescence. The validity and the accuracy of the significance
estimations are, therefore, important. Here, we calculated a
ratio of change in gene expression that concurs with the tran-
sition from one biological state to another. By comparing
changes in gene expression rather than absolute measures
several advantages were achieved. Effects on absolute meas-
ures of expression level - such as array type differences in
ability to quantify transcript abundance, or species and tissue
differences in background gene expression - were eliminated.
As a consequence, biased correlations within species or
between identical arrays are probably of limited concern.
Also, all the expression data were used in the comparison,
which would not have been the case if genes differentially
expressed above a certain threshold had been compared.
Thus, the changes in gene expression could be compared to
changes in other experiments, regardless of species and the
microarray platform used. The ratio approach that we used
cannot be applied without considering the biological condi-
tions studied. This is demonstrated by the fact that we were
unable to establish similarity between senescence and aging
when a gene expression ratio of senescent to proliferating
cells was used to describe a senescent transcriptome signa-
ture. Similarity became evident when the proliferating cell
data were replaced with quiescent cell data, that is, when cell-
growth differences no longer obscured the comparison.
Distributions of random correlations were produced for each
study-to-study comparison and used to assess the signifi-
cance of the correlation in that comparison. It might be
argued that such simulations underestimate the variance of
the true distribution as they assume that all probes (or genes)
will display similar changes in signal intensity. In a study [11]
where genes were randomly paired within quantiles of overall
hybridization intensity, however, the resulting distributions
of correlations did not show a significantly increased vari-
ance. We consider the statistical methods applied in this
study solid, and conclude that many of the correlations
obtained in this study are highly unlikely to occur by chance.
Yet, it is possible that circumstantial factors may have con-
tributed to unexpected correlations. Any unintentional
Robust transcriptome signatures of cellular senescence and aging Figure 3 (see previous page)
Robust transcriptome signatures of cellular senescence and aging. (a) Fifty-five pair wise comparisons of eleven aging and senescence datasets are divided 
into groups on the basis of the nature of the comparison: aging versus aging (n = 21), aging versus senescence (n = 28), and senescence versus senescence 
(n = 6). The aging versus aging group is further divided into within species, within tissue, and across species and tissue groups (the highly correlating aging 
mouse cerebellum to cortex comparison can not be allocated to any of these groups, as it is 'within species and tissue'). Bars represent the correlation in 
each comparison. The continuous line represents a threshold for significance corresponding to a Bonferroni corrected P value < 0.005, as determined by 
the random distributions of correlations. The dotted line represents the maximum correlation in that distribution (10,000 iterations). (b) Analysis of the 
average Z-score (displacement from the random distribution of correlations in numbers of standard deviations) for the aging versus aging, aging versus 
senescence, and senescence versus senescence groups. Only the aging versus aging and the senescence versus senescence groups have a mean that passes 
a t test for being different from zero. (c) Identical analysis of the within species, within tissue, and across species and tissue groups. Only the within species 
group has a mean that passes a t test for being different from zero. In (b,c), P values and tails represent the P value for having a mean different from zero, 
and the 95% confidence interval for the mean, respectively.R109.8 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. http://genomebiology.com/2005/6/13/R109
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source of effects on gene expression, transcript abundance or
hybridization efficiency that is unevenly distributed between
the case and control groups, in two or more datasets, could
promote 'false' correlations. The occurrence of such false pos-
itive correlations between processes with no known similarity
seems to be a lesser issue, however, as a study in which a sim-
ilar approach to identify similarities of changes in global
expression was applied identified no correlations >0.06 when
comparing 320 unrelated studies [11]. The correlations of all
our summaries that we consider significant were above 0.06.
To assess a biological similarity we used several studies and
averaged the correlation in the aging-aging, aging-senes-
cence, and senescence-senescence comparison groups. This
should further limit the risk of a false positive leading to a
false conclusion. A non-significant correlation between proc-
esses that indeed are similar would be caused by variation in
the individual studies. The main source of variation on the
Affymetrix platform, when the normalization approach we
used is applied, appears to be biological (compared to
technical) [13]. In our approach we carefully assessed the
technical quality of the individual studies, thereby limiting
the risk of a non-significant result because of technical varia-
tion. In addition, each study we used was well replicated and
able to show similarities to at least one other study in our
comparisons, indicating that the biological variation did not
limit the appearance of positive correlations. A full under-
standing of the risk of false negative correlations would need
a large, controlled study where the expression changes of a
priori known similar processes were compared across, for
example, laboratories, platforms and labelling protocols. In
our study, the calculated P values for the group of expression
patterns supported average similarity, indicating that the
data should be considered robust. We claim that a valid result
can be obtained if the unmodified and robust Monte Carlo
simulation is used to approximate significance and the simi-
larities obtained are present in repeated comparisons of sim-
ilar biological states.
Using these methods, we observed a shared expression signa-
ture in mammalian aging. Furthermore, we found that aging
is more different across species than across organs of the
same species. This finding is intuitive, given the differences
between the organisms in terms of life span. Humans have a
lifespan that is about 40 times that of mice. It seems possible
that the aging phenotype that is allowed to develop during an
80 year life span would be different from that produced
during a two to three year life span. In this perspective, it
might even seem surprising that some of the cross species but
within tissue comparisons give rise to significant correlations.
Our findings argue for complexity in the aging program: one
component is species specific and is manifested in all organs;
another component is organ specific and can give rise to cor-
relation within organs, across species.
An interesting finding in the present study is the detection of
a senescence-like component within the murine aging gene
expression pattern. This correlation could either occur as a
consequence of an accumulation of senescent cells or by a
phenotypic change of normal cells towards a senescent phe-
notype. In either case, the tissue seems to become more
similar to senescent cells as it ages. It may appear contradic-
tory that mice, with a much shorter life span and significantly
longer telomeres than humans, would display a senescent like
phenotype, as senescence is believed to occur as a result of
extended cell division and telomere erosion. Cellular stress is
an alternative mechanism of senescence induction, however,
and the overlap between aging and senescence that we
observe could be caused by stress-induced senescence. There
are indications in the literature that stress is a general path-
way towards senescence; for example, human primary cells
can senesce because of replicative exhaustion or cellular
stress [14]. A contribution of stress is also observed during
RAS induced senescence. Over-expression of RAS seems to
induce senescence in cells with high levels of p16 by further
increasing the p16 expression. In contrast, cells with low lev-
els of p16 only attain moderate levels of p16 after RAS over-
expression and, therefore, do not senesce [15]. Thus, senes-
cence can be induced by both telomeres, via p53/p21, and cel-
lular stress independent of telomere length, characterised by
p16 over-expression. The signalling pathways of telomere
induced senescence and stress induced senescence are
believed to overlap. This is supported by our study where the
Table 2
Included senescence studies
Study Chip type Species Cell type Induction of senescence
Zhang et al. [21] Stanford, cDNA Human Fibroblasts Serial passaging
Schwarze et al. [31] Stanford, cDNA Human Prostate epithelial cells Serial passaging
Zhang et al. [20] Stanford, cDNA Human Mammary epithelial cells Serial passaging
Larsson et al. [22] MG U74 Av2 Mouse Thymus epithelial cells Heat inactivation of SV40 
large T antigen
All studies of senescence that were used in the aging to senescence comparisons are listed. Platform, species, cell type and senescence model are 
shown.http://genomebiology.com/2005/6/13/R109 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. R109.9
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transcriptional changes with senescence induced by telomere
shortening and stress correlate highly. Furthermore, if stress-
induced senescence occurs in vivo in mice, one would expect
p16 to accumulate with age. This is supported by a recent
study where p16 was identified as a biomarker of aging in
mice in a range of organs [10]. Taken together, these results
indicate that aging mouse cells could be stressed in vivo and
that senescence could occur as a consequence of stress.
Similarity in the transcriptome signatures of senescence and mouse aging Figure 4
Similarity in the transcriptome signatures of senescence and mouse aging. (a) Two senescence datasets, where data derived from proliferating cells 
(denominator in ratio of differential expression with senescence) have been replaced by data derived from quiescent cells, are compared to seven aging 
datasets. Arrows represent the Pearson correlation in each comparison. Distributions of correlations produced by random pairing of genes are displayed 
as density curves. P values (calculated using the random correlation distributions as a reference) and numbers of gene or ortholog pairs (present in the 
individual comparison) are displayed in the top right part of each figure. (b) Left: analysis of the average Z-score for groups of comparisons. Only the six 
comparisons of senescence (mouse and human) and mouse aging (cerebellum, neocortex and heart) have a mean that passes a t test for being different 
from zero. Right: similar analysis of mean Pearson correlations for the same groups, producing the same result. In (b), P values and tails represent the P 
value for having a mean different from zero, and the 95% confidence interval for the mean, respectively.
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Intriguingly, we were unable to establish any similarities
between cellular senescence and human tissue aging. One
might argue that the low availability of human senescence
studies where senescent cells could be compared to quiescent
cells limits our analysis. This is unlikely, however, as not only
the mouse senescence study, but also the human senescence
Table 3
Gene Ontology categories correlating in six comparisons of senescence and mouse aging data sets
Gene Ontology category Human senescence Mouse senescence
Aging mouse 
cerebellum
Aging 
mouse 
neocortex
Aging mouse 
heart
Aging mouse 
cerebellum
Aging mouse 
neocortex
Aging mouse 
heart
ATP biosynthesis
GO:0006754
P = 0.00648 - P = 0.019 P = 0.00262 P = 0.0135 P = 0.0222
Hydrogen-exporting
ATPase activity
GO:0008553
P = 0.0284 - P = 0.00701 P = 0.00293 - P = 0.00394
Pre-mRNA splicing factor activity
GO:0008248
-- P = 0.0229 P = 0.00199 P = 0.00533 P = 0.000848
Hydrogen ion transporter activity
GO:0015078
P = 0.0134 - P = 0.00532 P = 0.000814 - P = 0.023
Mitotic sister chromatid segregation
GO:0000070
--- P = 0.000947 P = 0.0462 P = 0.0103
Nuclear mRNA splicing via spliceosome
GO:0000398
-- P = 0.022 P < 0.000001 - P = 0.000918
Spliceosome complex
GO:0005681
--- P = 0.000124 P = 0.00589 P = 0.0199
Lysosome
GO:0005764
-- P = 0.00545 P = 0.00641 - P = 0.0449
Protein folding
GO:0006457
P = 0.0469 - - P = 3.47e-06 P = 1.25e-05 -
Regulation of cell cycle
GO:0000074
--- P = 1.74e-05 P = 0.00372 P = 0.0083
Metalloendopeptidase activity
GO:0004222
P = 0.0012 P = 0.0115 - - - P = 0.00277
Nucleus
GO:0005634
--- P = 0.000188 P = 0.00143 P < 0.000001
Chaperonin-containing
T-complex
GO:0005832
P = 0.0447 - - P < 0.000001 P < 0.000001 -
Negative regulation of cell proliferation
GO:0008285
-- P = 0.00615 P = 0.00636 - P = 0.00246
Proton transport
GO:0015992
-- P = 0.0126 P = 0.00713 - P = 0.0042
Endoplasmic reticulum
GO:0005783
- P = 0.0402 - - P = 0.0372 P = 0.0272
Cytoskeleton
GO:0005856
--- P = 0.0347 P = 0.0308 P = 0.0251
RNA binding
GO:0003723
--- P = 0.00305 P = 0.0112 P = 4.89e-05
Cytoplasm
GO:0005737
--- P = 0.0137 P = 0.00965 P = 5.49e-05
Respiratory gaseous exchange
GO:0007585
--- P = 6.25e-05 P = 8.77e-06 P < 0.000001
Gene Ontology categories correlating in six comparisons of senescence (human and mouse) and mouse aging datasets. Shown are P values for partial 
summations of the Pearson correlation for individual Gene Ontology categories. The P values were calculated using Monte Carlo simulations as a 
reference. Only categories beyond the third branch in the Gene Ontology tree, appearing in more than two of six comparisons, are included. - 
signifies p > 0.05.http://genomebiology.com/2005/6/13/R109 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. R109.11
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study, showed similarities to mouse aging. This indicates that
the similarities between aging and senescence are robust and
less dependent on species. When the quiescence controlled
senescence studies and human aging studies were compared,
only one comparison showed a significant similarity. Given
the robustness of the senescence to mouse aging compari-
sons, and the overlap between mouse aging and human
senescence, it seems likely that if senescence were a pro-
nounced phenotype of human agi n g ,  i t  s h o u l d  h a v e  b e e n
observed with the technique used presently.
A possible explanation for the difference between the correla-
tion between senescence and aging in mouse and humans,
respectively, is the difference in sensitivity to reactive oxygen
species. Mice produce more reactive oxygen species [16].
Hence, reactive oxygen species may elicit more pronounced
damage in mice than in humans. This idea is supported by the
fact that human cells can proliferate indefinitely if telomerase
is expressed [17] whereas mouse cells with telomerase even-
tually enter senescence.
Accumulation of reactive oxygen species could, therefore,
induce expression of p16, which in turn might be part of the
process of aging in mice. In humans the oxidative stress effect
could be expected to be less pronounced and may not induce
senescence. The contribution of cellular senescence in human
aging may, therefore, be restricted to the telomere driven rep-
licative senescence. One could speculate that senescence
indeed occurs in vivo in humans, but to a much lesser extent
compared to mice. The effect of the senescent cells on the
overall function of the organ, and thereby their contribution
to aging, would then be expected to be less important. Other
possibilities are that apoptosis is the end point of telomere
erosion in humans, and that senescence down-stream of tel-
omere erosion is an in vitro phenomenon, or that senescence
does not generally occur in tissues but only affects stem cells
when these fail to escape stress induced senescence or are
unable to maintain their telomeres. Regardless of the expla-
nation, our data provide indications that the senescent phe-
notype does not dominate the aging tissues of humans.
Conclusion
By comparing changes in gene expression, it is possible to
identify conditions that share expression profiles. We found a
shared expression profile in aging mammals that seems to be
more robust within the species tested but also pronounced
within some organs across species. By comparing changes of
gene expression that occur during in vitro senescence to the
aging transcriptomes, senescence like changes in gene
expression characterise mouse aging but we could not detect
such a similarity in human tissue. Our data provide indica-
tions that the senescent phenotype does not dominate the
aging tissues of humans.
Materials and methods
Data collection and selection
PubMed was screened for studies of senescence or aging
where microarrays had been used to monitor global changes
in gene expression. Only studies with data derived from
human, mouse and rat were included. From the 34 publica-
tions that were considered, we were able to use data from 10
(excluded studies are listed in Additional data file 1). Studies
using microarrays containing less then 6,000 features were
excluded, as subsequent cross-array and cross-species com-
parisons would become less reliable due to relatively few data
points. Other studies were excluded beause we were unable to
obtain CEL files, robust multi-array average (RMA) normal-
ized data, or dChip normalized data from Affymetrix studies,
or raw data from cDNA-chip studies. Three studies were
excluded because of insufficient data quality (details on rea-
sons for exclusion of individual studies are listed in Addi-
tional data file 1). The data from the selected studies were
either downloaded [18,19] or obtained directly from the
authors.
In several cases, we excluded samples from individual data-
sets if the correlations to replicate samples were dramatically
different from other within-replicate correlations (details on
data selection can be found in Additional data file 2).
Normalization
A summary of the normalization methods used for each data-
set can be found in Additional data file 2. We normalized all
datasets but one, for which we obtained dChip normalized
data. All Affymetrix data were n o r m a l i z e d  w i t h  R M A ,  a l l
cDNA data were normalized using loess normalization with
default settings in the Bioconductor package LIMMA.
Allocation to case and control groups
For subsequent analysis, data needed to be divided into aged
and young groups and senescent and control groups. For the
aging data, this was straightforward, and the groups are sum-
marized in Table 1. Data on senescence were divided into
senescent and control groups. The control group consisted of
proliferating or quiescent cells. In the datasets by Zhang et al.
[20,21], samples from senescent and control populations had
been hybridized to the same microarray so that the differen-
tial expression between senescent and control populations is
represented by a single value (the data belong to a single
group). In the dataset by Larsson et al. [22], a temperature
sensitive inhibitor of senescence (SV40 large T antigen) was
used. To subtract differential expression caused by the tem-
perature shift, wild-type (with a temperature insensitive
SV40 large T antigen) cells were used as a reference, yielding
four groups instead of two: cells with or without the tempera-
ture sensitive senescence inhibitor, each divided into permis-
sive temperature groups and restrictive temperature groups.
We used data for the 0 h and 72 h time points because the
other datasets contained samples from senescent cells har-R109.12 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. http://genomebiology.com/2005/6/13/R109
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vested days after senescence induction. Additional informa-
tion on specific datasets is available in Additional file 3.
Annotation
We used the RESOURCERER tool [23] for annotation and
cross-referencing of platforms. Individual features in all data-
sets were assigned unique and unambiguous identifiers, spec-
ifying the gene and its orthologs, thus making cross array and
species comparisons possible. For the datasets using Affyme-
trix MU6500 and U74A chips (annotation information not
available within the RESOURCERER tool), additional anno-
tation information was downloaded [24] and used for cross-
reference to the identifiers given by RESOURCERER (for
details see Additional data file 3).
Calculation of differential gene expression measures
Normalized log2 expression measures were used to produce
an expression ratio:
Ri = (1/nj × Σ  xj) - (1/nk × Σ  xk)
where i is a specific feature on a microarray and x represents
the log2-transformed expression measures for that feature on
all chips in the experiment. Values for x belong to the aging
(or senescent; j) group, or to the young (or senescence con-
trol; k) group. nj and nk indicate the number of chips in the j
and k groups. Thus, the geometric mean of the expression
measures from the aging (or senescent) samples was divided
by the geometric mean of the expression measures from the
young (or control) samples, giving rise to a measure of differ-
ential expression with aging or senescence. This removes all
expression differences produced by irrelevant variables (for
example, chip type and species) because these variables will
be identical in the two groups. Ratios from different features,
probing the same gene, were averaged. This way of calculat-
ing a differential expression ratio was applied to all Affyme-
trix studies and to all cDNA microarray data where a common
reference sample was used for competitive hybridization. In
the Zhang et al. [20,21] studies, senescent and control sam-
ples were competitively hybridized to the same chip, thus no
individual expression measures for senescent or control
groups can be derived. In this case, the average normalized
expression measure for an individual feature across arrays in
the experiment was considered an equivalent of Ri and only
subjected to averaging within the same gene.
In the study by Larsson et al. [22], four groups were used for
calculating differential expression, and the expression of the
ratio was adapted:
Ri = ((1/nj × Σ  xj) - (1/nk × Σ  xk)) - ((1/nl × Σ  xl) - (1/nm × Σ
xm))
Where j, k, l and m correspond to the four groups: cells with a
temperature sensitive (j, k) or insensitive (l, m) SV40 large T
antigen divided into restrictive (j, l) and permissive (k, m)
temperature groups.
Correlation
Having annotated all datasets using one set of identifiers, and
transformed all data for a single gene in an individual dataset
to a ratio of differential expression, two or more datasets
could be assessed with regards to their correlation. We used
Pearson, Spearman and Kendall models of correlation for all
comparisons, and they produced consistent results. We have
chosen to present Pearson correlations only.
Monte Carlo simulations
To assess the significance of individual correlations, we itera-
tively (10,000 times) and randomly paired all genes between
the two datasets compared, and calculated the Pearson,
Spearman and Kendall correlations. Thus, a distribution of
random correlations for each comparison was produced,
serving as a reference for each correlation measure.
Calculation of P values for correlation measures
The correlation values produced by the Monte Carlo simula-
tions were normally distributed. We used values for means
and standard deviations of these distributions to calculate P
values for the actual correlation in each comparison. We used
Student's t tests to assess the means of groups of compari-
sons, with regards to their P  values and 95% confidence
intervals.
Confluent cells as a reference for senescence
In the Zhang et al. [21] and Larsson et al. [22] studies, quies-
cent/confluent - rather than proliferating - cells had also been
used to provide alternative controls for the senescent cell
models. To remove effects of cell proliferation differences
(between control data in the aging and senescence studies) on
the gene expression signature of senescence, we used the data
derived from quiescent cells. For the Zhang et al. dataset,
where the senescence and control samples have been hybrid-
ized to the same array, we simply used the senescence versus
quiescence data. For the Larsson et al. dataset, the log2
expression measures from the temperature permissive group
was replaced by the expression measures from the confluent
group, in the k entry of the ratio expression above.
Analysis of Gene Ontology categories giving rise to 
correlation between mouse aging and mouse and 
human senescence
We analysed the six comparisons of senescence (human and
mouse) and mouse aging that showed average correlation.
For all Gene Ontology categories, with more than two genes
present in a specific comparison, we calculated the partial
summation of the Pearson Correlation:
rj = Σ  (xj - µx)(yj - µy)/nσ xσ yhttp://genomebiology.com/2005/6/13/R109 Genome Biology 2005,     Volume 6, Issue 13, Article R109       Wennmalm et al. R109.13
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where j is the set of ortholog pairs associated with that Gene
Ontology category, µx, µy and σ x, σ y are the means and stand-
ard deviations of expression ratios for all genes or orthologs
appearing in the comparison (the entire study to study com-
parison), and n is the total number of genes. Statistical signif-
icance was assessed by performing Monte Carlo simulations
for individual Gene Ontology categories. Random pairing of
genes was followed by random assignment to gene ontology
categories, and repeated 10,000 times. Calculations of P val-
ues were performed as described above for the calculation of
P values of correlations between entire datasets.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 lists the excluded
studies and the reasons for their exclusion. Additional data
file 2 provides details on data selection and the normalization
methods used for each data set. Additional data file 3 provides
i n f o r m a t i o n  o n  h o w  d a t a  w a s  a l l o c a t e d  t o  c a s e  ( a g i n g  o r
senescent) and control (young, proliferating or quiescent)
groups as well as on the cross-referencing of microarrays.
Additional data file 1 The excluded studies and the reasons for their exclusion The excluded studies and the reasons for their exclusion. Click here for file Additional data file 2 Details on data selection and the normalization methods used for  each data set Details on data selection and the normalization methods used for  each data set. Click here for file Additional data file 3 Information on how data was allocated to case (aging or senescent)  and control (young, proliferating or quiescent) groups as well as on  the cross-referencing of microarrays Information on how data was allocated to case (aging or senescent)  and control (young, proliferating or quiescent) groups as well as on  the cross-referencing of microarrays. Click here for file
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